Cancer epidemiologyHumansMetforminColorectal NeoplasmsMaleFemale
The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness.
Yehudit Peerless, Gal Strauss, Ofer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, Ben Boursi
Published: 202610.1016/j.canep.2025.102983
Abstract
BACKGROUND: Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. Tumor sidedness influences treatment decisions for metastatic disease due to differences in biology and therapeutic response. Metformin, an anti-diabetic…
Preview only. Read the full abstract at the source